This episode outlines the basics of the 340B Drug Pricing Program and discusses potential changes affecting the program, including CMS’s recent proposal to cut reimbursement for Part B drugs purchased under the 340B program. Additionally, a draft Executive Order currently circulating from the Trump Administration suggests that more significant changes may be in the program’s near future.

Click here to view podcast